Chrousos Phaedra 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2025-06-05+59,225→ 123,350 total
Footnotes (1)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.